Reading the tape
NASDAQ: RKDA
Arcadia Biosciences, Inc.
Basic Materials · Agricultural Inputs
Market Cap
$1.57M
52w High
$6.71
52w Low
$0.89
P/E
-0.67
Volume
7.29K
Outstanding Shares
1.37M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -69.51%Revenue (TTM): -3.73%FCF (TTM): 50.86%P/S: 0th pct
What changed
The stock fell 69.51% over the last year. Revenue declined 3.73% over the trailing twelve months. Operating margin moved from -72.28% to -51.42%. Free cash flow grew 50.86% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -51.42%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States.
CEOThomas J. Schaefer
SectorBasic Materials
IndustryAgricultural Inputs
Employees9
IPO dateMay 15, 2015
Valuation
Forward P/E—
EV/EBITDA-0.25
Enterprise value$2.45M
Stock splits
Mar 1, 2023↓ Reverse
Every 40 shares became 1
Jan 24, 2018↓ Reverse
Every 20 shares became 1
Profitability & growth
Revenue growth-25.9%
Gross margin36.21%▼12.21%vs FY2024
Operating margin-51.42%▼184.53%vs FY2024
ROE-56.5%▲50.04%vs FY2024
Analyst consensus
RatingBuy
Target price$6.00▲421.74%
4
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$0.80 · Revenue est $1.6M
View